Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas, +4969

The Lancet

LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers

Jinghua Pan, Hong Zhou, Laura Cooper, +6

Frontiers in Immunology

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi, +2419

JAMA

Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity

Zhengnan Shen, Kiira Ratia, Laura Cooper, +10

Journal of Medicinal Chemistry

Molecular DockingMedicineSars-cov-2 Plpro InhibitorsImmunologyEssential Cysteine Proteases +11

Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors

Ana Sol Peinetti, Ryan J. Lake, Wen Cong, +10

Science Advances

Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants

Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, +12

Nature Chemical Biology

Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases

Zinuo Chen, Qinghua Cui, Laura Cooper, +7

Cell & Bioscience

Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro

Ruikun Du, Laura Cooper, Zinuo Chen, +3

Antiviral Research

Pharmaceutical ChemistryBiochemistryMedicineAntiviral Drug DevelopmentSars-cov-2 3Clpro +8

Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry

Enya Qing, Pengfei Li, Laura Cooper, +5

Cell Reports

Viral ReplicationAuthentic Virus-cell EntryViral PathogenesisImmunologyMolecular Biology +14

An <scp>ACE2</scp> decoy can be administered by inhalation and potently targets omicron variants of <scp>SARS‐CoV</scp> ‐2

Lianghui Zhang, Krishna K. Narayanan, Laura Cooper, +9

EMBO Molecular Medicine